Sign in
Active, not recruitingNo phase

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

Key facts

Who runs it
Washington University School of Medicine
Where
Baltimore, Chapel Hill, Charlottesville, Chicago, Cleveland, Evanston, Indianapolis, Iowa City, Jackson, La Crosse, Lincoln, Milwaukee, New Haven, New York, Newark, NewYork, Oklahoma City, Orange, Philadelphia, Pittsburgh, Plattsburgh, Portland, San Francisco, St Louis, Staten Island, and Toledo, United StatesSee the 29 sites
Trial code
Status
Active, not recruiting
People taking part
225 people enrolled
Started
2 Jul 2018
Ended
27 Apr 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Stents
Record updated
28 January 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Disabling (moderate-to-severe) PTS, defined by a) presence of chronic venous disease > or = 3 months duration in a leg with history of DVT, as determined by the site principal investigator or a physician co-investigator; and b) substantial limitation of daily activities or work capacity due to venous symptoms or an open venous ulcer, per the same investigator
  • Ipsilateral iliac vein obstruction documented within 12 months prior to consent by either:; Occlusion or >50% or = 50% stenosis of the iliac vein on venogram, CT venogram, MR venogram, or intravascular ultrasound (IVUS) or; Air plethysmography showing deep venous obstruction of the ipsilateral leg (reduced venous outflow fraction), and ultrasound showing echogenic material in the ipsilateral iliac vein and non-phasic continuous Doppler flow in the ipsilateral common femoral vein (CFV) in the presence of normal phasic Doppler flow in the contralateral CFV

Who cannot take part

  • Acute ipsilateral proximal DVT episode within the last 3 months, or acute contralateral DVT for which thrombolytic therapy is planned
  • Previous stent placement in the infrarenal IVC or ipsilateral iliac or common femoral vein
  • Chronic arterial limb ischemia (ankle-brachial index < 0.5 within the previous 1 month) in the ipsilateral leg (if peripheral arterial disease is present or suspected, an ankle-brachial index should be obtained and documented)
  • Presence of open venous ulcer > 50 cm2 area, suspicion for active ulcer infection, or visualization of bone or tendon within the ulcer in the ipsilateral leg
  • Inability to tolerate endovascular procedure due to acute illness, or general health
  • Severe allergy to iodinated contrast refractory to steroid premedication
  • Known allergy to stent or catheter components
  • Disseminated intravascular coagulation or other major bleeding diathesis
  • Hemoglobin < 8.0 g/dl, uncorrectable INR > 3.0, or platelet count < 75,000/ml
  • Severe renal impairment (on chronic dialysis or estimated GFR < 30 ml/min)
  • Age less than 18 years
  • Lack of suitable inflow into the ipsilateral common femoral vein per the treating physician
  • Absence of PTS of at least moderate severity
  • Pregnancy (positive pregnancy test)
  • Life-expectancy < 6 months or chronically non-ambulatory for reasons other than PTS
  • Inability to provide informed consent or to comply with study assessments; Note - patients who initially meet an exclusion criterion can have eligibility re-evaluated on a subsequent occasion

Where in United States

  • University of MarylandBaltimore, United States
  • University of North CarolinaChapel Hill, United States
  • University of VirginiaCharlottesville, United States
  • Rush Medical CenterChicago, United States
  • University of ChicagoChicago, United States
  • University Hospitals Cleveland Medical Center*Cleveland, United States
  • Northshore University Health SystemEvanston, United States
  • Northwestern UniversityEvanston, United States
  • Indiana UniversityIndianapolis, United States
  • University of IowaIowa City, United States
  • University of Mississippi Medical CenterJackson, United States
  • Gundersen Health SystemLa Crosse, United States
  • St. Elizabeth's HospitalLincoln, United States
  • Medical College of WisconsinMilwaukee, United States
  • Yale New Haven HospitalNew Haven, United States
  • New York University Medical CenterNew York, United States
  • Christiana Care HospitalNewark, United States
  • New York Presbyterian-Weill Cornell MedicineNewYork, United States
  • University of OklahomaOklahoma City, United States
  • St. Joseph's Vascular InstituteOrange, United States
  • Temple UniversityPhiladelphia, United States
  • Thomas Jefferson University HospitalPhiladelphia, United States
  • University of PittsburgPittsburgh, United States
  • University of Vermont Health Network - CVPHPlattsburgh, United States
  • Oregon Health Sciences UniversityPortland, United States
  • UCSFSan Francisco, United States
  • Washington University School of MedicineSt Louis, United States
  • Staten Island HospitalStaten Island, United States
  • Jobst Vascular InstituteToledo, United States

About the trial

What the trial wants to find out

The purpose of this study is to determine if the use of image-guided, endovascular therapy (EVT) is an effective strategy with which to reduce Post Thrombotic Syndrome (PTS) disease severity and improve quality of life in patients with established disabling iliac-obstructive post thrombotic syndrome (DIO-PTS).

The 2 groups in the trial

  • Endovascular TherapyTreatment being tested

    Subjects randomized to EVT will receive the following: 1. imaging-guided iliac vein stent placement; 2. anticoagulant therapy for at least 6 months; 3. oral aspirin 81 mg for at least 6 months; and 4. optimal PTS therapy: medical, compression, lifestyle measures, and venous ulcer care

    Treatment: Stents

  • No-Endovascular Therapy - ControlNo study treatment, for comparison

    Optimal PTS therapy: medical, compression, lifestyle measures, and venous ulcer care

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial
Publications
Record updated
28 January 2026